Compugen医疗 CGEN 深 沪
等待开盘 04-01 09:30:00 美东时间
2.13
+0.140
+7.04%
华盛通- 最 高2.15
- 今 开1.99
- 成交量 26.67万股
- 最 低 1.99
- 昨 收 1.99
- 总市值 2.01亿
- 52周最高 2.38
- 市盈率 静 5.65
- 换手率 0.28%
- 52周最低 1.23
- 委 比 9.96%
- 总股本 9455.41万
- 历史最高 19.90
- 量 比 1.86
- 振 幅 8.04%
- 历史最低 0.51
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Compugen Ltd. Director Sanford S. Zweifach Files Initial Beneficial Ownership Statement
Compugen Ltd. Director Sanford S. Zweifach Files Initial Beneficial Ownership Statement Sanford Zweifach filed an initial statement of beneficial ownership as a director of Compugen. The filing reported 12,680 ordinary shares beneficially owned directly. It also reported share options covering 10,00
03-18 18:33
Compugen Ltd. director Gilead Halevy files initial beneficial ownership statement
Compugen Ltd. director Gilead Halevy files initial beneficial ownership statement Gilead Halevy filed an initial statement of beneficial ownership for Compugen in connection with his role as a director. The filing reported direct ownership of 11,407 ordinary shares. It also listed share options to b
03-18 18:07
Compugen FY 2025 revenue rose 161.0% to USD 72.8 million
Compugen FY 2025 revenue rose 161.0% to USD 72.8 million Compugen reported FY 2025 revenue of USD 72.8 million, net profit of USD 35.3 million and financial and other income of USD 4.1 million. Cost of revenues was USD 9.3 million, while R&D expenses, net were USD 22.8 million (down 8%) and G&A expe
03-02 20:17
Earnings Breakdown: Compugen Q4
The Q4 earnings report for Compugen (NASDAQ:CGEN) was released on Monday, March...
03-02 20:02
Compugen Q4 EPS $0.60 Beats $0.05 Estimate, Sales $67.332M Beat $1.357M Estimate
Compugen (NASDAQ:CGEN) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.05 by 1100 percent. This is a 957.14 percent increase over losses of $(0.07) per share from the same
03-02 20:01
Compugen posts FY 2025 revenue of USD 72.8 million (+161.0%)
Compugen posts FY 2025 revenue of USD 72.8 million (+161.0%) Compugen reported Q4 FY 2025 revenue of USD 67.3 million (up from USD 1.5 million) and FY 2025 revenue of USD 72.8 million (up from USD 27.9 million), reflecting a USD 65 million upfront payment from AstraZeneca tied to monetization of a s
03-02 20:01
Earnings Scheduled For March 2, 2026
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
Uncovering Potential: Compugen's Earnings Preview
Compugen (NASDAQ:CGEN) is set to give its latest quarterly earnings report on M...
02-28 03:01
Compugen to Join Oppenheimer 36th Annual Healthcare Life Sciences Conference Fireside Chat
Compugen to Join Oppenheimer 36th Annual Healthcare Life Sciences Conference Fireside Chat Compugen Ltd. will participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026 (virtual) and the Leerink Partners 2026 Global Healthcare Conference on Monday,
02-19 20:02
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
